Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
61 ECC5004 The preliminary results of the investigational agent ECC5004 phase 1 trial in non-human primates revealed a reduction in HbA1c levels, accompanied by weight loss and a decreased risk of adverse cardiovascular events, achieved through the mimicry of the hormone GLP-1
2016 Oct;17(10):970-6
Ask Ivy or talk with our team during booking so we can point you toward the injection, IV drip, or medication option that best fits your goals
Evidence-level notice No clinical trial has tested retatrutide + MOTS-c together
We use Essential Phospholipids (EPL), which are made from non-GMO soy lecithin
US$ 22.80
US$ 28.47
US$ 29.54
US$ 26.86
US$ 20.63
US$ 22.86
US$ 26.80
US$ 23.35
US$ 20.98
US$ 27.98
US$ 29.75
